missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Quantikine Immunoassay Control Set 915 Human Myeloperoxidase
Elevated plasma MPO levels have been associated with a variety of clinical conditions including systemic inflammation, eclampsia, risk of cardiovascular events, vascular endothelial dysfunction, severity of multiple sclerosis, and prospective mortality and oxidative stress during hemodialysis
Marke: R&D Systems™ QC211
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
- For use as quantitative controls for the determination of cytokine concentrations in biological fluids
- Concentrations have been assigned using R&D Systems’ Quantikine™ kits
- Controls are prepared in diluted serum with preservatives
- They contain recombinant human cytokines at low, medium and high concentrations
- Controls are supplied lyophilized
Spezifikation
| Store the unopened product at 2°C to 8°C. Do not use past expiration date. | |
| 4353 (Human); 17523 (Mouse); 303413 (Rat) | |
| 1 Each |
| Quantikine Immunoassay Control Set 739 Human Myeloperoxidase | |
| Control |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
R&D Systems™ Quantikine Immunoassay Control Set 915 Human Myeloperoxidase > Immunoassay Control Set 739 Human Myeloperoxidase
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur